Morpholine → HCID 67157674, compound

HRID 548865Notes

Reaction equation

C(O[C:4]([C:6]1[N:7]=[N:8][C:9]([O:12][CH2:13][C:14]2[C:15]([C:20]3[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=3)=[N:16][O:17][C:18]=2[CH3:19])=[CH:10][CH:11]=1)=[O:5])C.[NH:27]1[CH2:32][CH2:31][O:30][CH2:29][CH2:28]1>>[F:26][C:23]1[CH:22]=[CH:21][C:20]([C:15]2[C:14]([CH2:13][O:12][C:9]3[N:8]=[N:7][C:6]([C:4]([N:27]4[CH2:32][CH2:31][O:30][CH2:29][CH2:28]4)=[O:5])=[CH:11][CH:10]=3)=[C:18]([CH3:19])[O:17][N:16]=2)=[CH:25][CH:24]=1

Participants

Reactant 2

HCID 8083Morpholine

HCID 42630252HCID 42630252, compound

Product 1

HCID 67157674HCID 67157674, compoundYield 83%

Procedure

As described for example 59, 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridazine-3-carboxylic acid ethyl ester (143 mg, 0.4 mmol) was converted, using morpholine instead of aminomethylcyclopropane, to the title compound (132 mg, 83%) which was obtained as a light yellow solid. MS: m/e=399.1 [M+H]+.

Sources & evidence

ORD record: ord-b10e6a76a9c440fb898bbb4fa6462283
Source dataset: uspto-grants-2011_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07943619B2

Reaction notes

Loading…